Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Obesity

Novartis Antibody Bimagrumab Evidences Results in Small Phase 2 Obesity Study

A Novartis investigational product called Bimagrumab recently raised attention in the obesity research community. The human monoclonal antibody was designed to treat muscle […]

Novartis Antibody Bimagrumab Evidences Results in Small Phase 2 Obesity Study
1 month ago
Share

ActRII-Blocking Antibody May Be a Novel Medicine for Obesity

A January 13 study published in JAMA Network Open looks at the “Effect of Bimagrumab vs. Placebo on Body Fat […]

ActRII-Blocking Antibody May Be a Novel Medicine for Obesity
2 months ago
Share

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency

This week, Rhythm Pharmaceuticals, a biopharmaceutical company specializing in the treatment of rare genetic diseases surrounding obesity, announced the U.S. […]

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE™ (setmelanotide) as First-ever Therapy for Chronic Weight Management in Patients with Obesity Due to POMC, PCSK1 or LEPR Deficiency
3 months ago
Share

With Growing Obesity in Korea, Alvogen Korea’s Qsymia Bumps Novo Nordisk Saxenda for the Number One Spot

Obesity represents big business and big problems. The condition has essentially tripled since the 1970s as raising middle classes around […]

With Growing Obesity in Korea Alvogen Korea’s Qsymia Bumps Novo Nordisk Saxenda for the Number One Spot
6 months ago
Share

Male Patients Categorized as Severely Obese Twice as Likely to Die from COVID-19

Kaiser Permanente Southern California researchers reviewed data covering almost 7,000 COVID-19 patients treated between February and May 2020. Nearly half […]

Male Patients Categorized as Severely Obese Twice as Likely to Die from COVID-19
6 months ago
Share

Kaiser Permanente SoCal Research & Evaluation Retrospective Study: COVID-19 Death Rates Spike with Male Under 60 & Obese

A team of researchers from Kaiser Permanente concluded in a study that obesity increases the risk of death from SARS-CoV-2, […]

Kaiser Permanente SoCal Research & Evaluation Retrospective Study COVID-19 Death Rates Spike with Male Under 60 & Obese
7 months ago
Share

UB School of Pharmacy Investigators Awarded Over $10m & Full Throttle on Critical & Timely Studies

A research team from the University of Buffalo School of Pharmacy and Pharmaceutical Sciences have received $10 million to commence […]

UB School of Pharmacy Investigators Awarded Over $10m & Full Throttle on Critical & Timely Studies
10 months ago
Share

Eisai’s Weight Loss Drug Belviq Pulled from Market Over Cancer Risk

The FDA has requested that Eisai, the manufacturer of Belviq, Belviq XR (lorcaserin), voluntarily withdraw the weight-loss drug from the […]

Eisai's Weight Loss Drug Belviq Pulled from Market Over Cancer Risk
1 year ago
Share

Eisai Pharmaceuticals Takes Obesity Drug Off Market as it May Increase Risk of Cancer

Japan-based Eisai Pharmaceuticals pulled its anti-obesity drug Belviq from the U.S. market due to reports that it is associated with […]

Eisai Pharmaceuticals Takes Obesity Drug Off Market as it May Increase Risk of Cancer
1 year ago
Share

Cedars-Sinai Receives $9.1m for Liver Cancer Clinical Research in Anticipation of Obesity Crisis and Liver Fat Risk

Cedars-Sinai investigators have received $9.1 million by the National Cancer Institute to study how fat can promote cancer’s spread to […]

Cedars-Sinai Receives $9.1m for Liver Cancer Clinical Research in Anticipation of Obesity Crisis and Liver Fat Risk
1 year ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.